Global Respiratory Devices Market Overview:
Respiratory devices supply respiratory gas instinctively to patients with impaired respiratory function. The respiratory gas is typically enhanced with oxygen and conveyed into the lung with a positive pressure created by the device. During controlled respiration, the ventilator fully assumes the patient's respiration effort with predetermined respiratory volume or pressures, while in assisted respiration the respiratory device only supports the spontaneous breathing effort with a set overpressure. Modern respiratory devices automatically regulate the inhalations and exhalations as per the requirement of the patients. Respiratory devices are available in different varieties as emergency respiratory devices for long-term respiratory devices for intensive care and mobile home respiratory devices.
- Increasing Prevalence of Respiratory Diseases
- Strict Government Regulations Regarding the Use of Respiratory Protection Equipment Mask
- Rising Demand for Home Care Respiratory Devices
- Rising Awareness Associated With Individual Safety and Security at Workplace
- Lack of Awareness about Respiratory Protection Equipment in Developing Region
- Increasing Awareness and Improvement in the Healthcare Infrastructure in Emerging Economies
- Huge Demand for Diagnostic Tools to Deliver a Reliable Diagnosis of Asthma in Young Children
- Availability of Substitutes in Market
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies.
Some of the key players profiled in the report are First Sensor AG (Germany), Philips Healthcare, (Netherlands), Medtronic plc (Ireland), ResMed Inc. (United States), Masimo Corporation (United States), Fisher & Paykel Healthcare Co. Ltd. (NewZealand), Getinge AB (Sweden), Air Liquide (France), Drägerwerk AG & CO.KGAA (Germany), Hamilton Medical AG (Switzerland), Invacare Corporation (United States), Vyaire Medical (United States) and Chart Industries, Inc. (United States). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Respiratory Devices market by 2025. Considering Market by End-Use, the sub-segment i.e. Hospital will boost the Respiratory Devices market.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Respiratory Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Respiratory Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Respiratory Device, Suppliers of Respiratory Device, Wholesalers, Distributors and Retailers of Respiratory Device, Healthcare Industry, Regulatory Bodies and Governmental Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.